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Aim To investigate urban-rural differences in the distribu-
tion of risk factors for breast cancer.
Methods We analyzed the data from the first round of the 
“Mamma” population based-screening program conduct-
ed in Croatia between 2007 and 2009 and self-reported 
questionnaire results for 924 patients with histologically 
verified  breast  cancer.  Reproductive  and  anthropomet-
ric characteristics, family history of breast cancer, history 
of breast disease, and prior breast screening history were 
compared between participants from the city of Zagreb 
(n = 270) and participants from 13 counties with more than 
50% of rural inhabitants (n = 654).
Results The screen-detected breast cancer rate was 4.5 
per 1000 mammographies in rural counties and 4.6 in the 
city of Zagreb, while the participation rate was 61% in rural 
counties and 59% in Zagreb. Women from Zagreb had sig-
nificantly more characteristics associated with an increased 
risk of breast cancer (P < 0.001 in all cases): no pregnancies 
(15% vs 7%), late age of first pregnancy (≥30 years) (10% 
vs 4%), and the most recent mammogram conducted 2-3 
years ago (32% vs 14%). Women from rural counties were 
more often obese (41% vs 28%) and had early age of first 
live birth (<20 years) (20% vs 7%, P < 0.001 for both).
Conclusion  Identification  of  rural-urban  differences  in 
mammography use and their causes at the population lev-
el can be useful in designing and implementing interven-
tions targeted at the reduction of inequalities and modifi-
able risk factors.
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Significant  differences  in  breast  cancer  frequency  have 
been identified in different socioeconomic groups, ethnic 
groups, and between urban and rural populations (1,2). Liv-
ing in rural areas may be associated with lower access to 
health care and mammography screening (3), as well as 
with late-stage diagnosis (4). This often means that patients 
need to travel great distances to receive care (5). Blair et al 
found that people in rural and urban areas were diagnosed 
with breast cancer at similar stages of the disease, although 
those from rural communities lacked basic cancer informa-
tion because they did not have access to cancer education 
programs offered in urban areas (6). Robbins et al explained 
the higher breast cancer incidence in the San Francisco 
Bay Area than in other regions by known risk factors: par-
ity, age at first full-term pregnancy, breast-feeding, age at 
menarche, and age at menopause (7). In Croatia, Polašek et 
al found that in a period without a national cancer screen-
ing program access to health care was the strongest cancer 
screening utilization predictor in adult rural population (8).
Risk factors for breast cancer are mostly those related to the 
reproductive life of women (9,10): menarche, nulliparity or 
late age at first birth, late menopause, as well as hormonal 
factors, be they endogenous or exogenous (eg, term use of 
oral contraceptives or menopausal hormonal replacement). 
Other risk factors related to hormonal status include obesity 
and a diet characterized by a high caloric intake, low intake 
of fruits and vegetables, and lack of physical activity (11). Ra-
diation, in particular during breast development, was also 
found to be a risk factor (12), while the role of contaminants, 
such as xenoestrogens and certain pesticides, remains con-
troversial. Four- to 5-fold risk of developing breast cancer 
was associated with epithelial proliferative lesions, particu-
larly atypical ductal or lobular hyperplasia (11).
In Croatia, breast cancer is the leading cancer among wom-
en, amounting to 27% of new female cancer cases; more-
over, the incidence rate in 2007 was 17% higher than in the 
previous year (13). In 2007, cancer incidence by county and 
age-standardized rates per 100 000 women varied consid-
erably: from 273.1 (Šibensko-kninska county) to 437.7 (the 
city of Zagreb), but the prevalence of breast cancer risk fac-
tors remains unknown. A government-funded mammog-
raphy screening program was established in October 2006 
and has since been implemented in 21 counties, including 
the city of Zagreb (14).
Population-based screening for breast cancer is conduct-
ed through mammographic examination of all women of 
a specified age at prescribed time intervals. The implemen-
tation of population-based screening requires technical re-
sources and trained personnel for double reading of mam-
mograms, as well as a major media campaign (15).
Within a more extensive study of breast cancer risk factors, 
this  study  investigated  urban-rural  differences  in  repro-
ductive, anthropometric, and family history of breast can-
cer and personal history of breast disease among women 
aged 50-69 from 13 rural counties and the city of Zagreb 
who participated in the first round of population-based 
mammography screening in Croatia.
MaterialS and MethodS
“Mamma” screening program
Organized population-based screening program in Croatia 
started in November 2006 on a target population of women 
aged 50-69. Coordinators from the Public Health Institutes 
from 21 counties distributed the invitations and coordinat-
ed the program at the county level. A separate database 
was formed for each county and the central unit had access 
to each of these databases through a common server lo-
cated at the Croatian Ministry of Health and Social Welfare. 
The program is centrally coordinated by the Croatian Na-
tional Institute of Public Health and includes 81 mammog-
raphy units and more than 200 radiologists. Double reading 
is obligatory; if the result is normal, women are sent a letter 
of invitation to another routine screening in 2 years. If the 
result is abnormal, women and their family physicians are 
informed about the need for further assessment (14).
We used the Organisation for Economic Co-operation and 
Development definition of rural and urban from the Croa-
tian Rural Development Strategy 2008-2013 of the Croatian 
Ministry of Agriculture, Fisheries, and Rural Development 
(16). Rural counties were considered those with a popula-
tion density of 150 people or fewer per square mile and 
more than 50% of rural inhabitants (16). Out of 21 counties, 
we identified 13 rural counties with a total population of 
1 926 219 people: Bjelovarsko-bilogorska, Brodsko-posavs-
ka, Karlovačka, Koprivničko-križevačka, Krapinsko-zagorska, 
Ličko-senjska,  Požeško-slavonska,  Sisačko-moslavačka, 
Šibensko-kninska,  Virovitičko-podravska,  Vukovarsko-Sri-
jemska, Zadarska, and Zagrebačka county. From the group 
of urban counties, we selected the county of city of Za-
greb (population: 779 145), which is the county with the 
highest population density. We excluded 5 counties with 
fewer than 50% rural inhabitants and Varaždin county 
due to lack of data (16).PUBLIC HEALTH 78 Croat Med J. 2011; 52: 76-86
www.cmj.hr
Participants
The  first  round  of  the “Mamma”  screening  program  in-
cluded 80 092 women aged 50-69 from the city of Zagreb 
and 184 425 from 13 rural counties. Participation in the 
screening program was free and based on an invitation. Of 
204 352 women screened from 2007-2009, 924 were found 
to have breast cancer. Of these, 270 were from the city of 
Zagreb and 654 from rural counties: Bjelovarsko-bilogor-
ska, 56; Brodsko-posavska, 64; Karlovačka, 42; Koprivničko-
križevačka,  47;  Krapinsko-zagorska,  41;  Ličko-senjska,  16; 
Požeško-slavonska, 32; Sisačko-moslavačka, 45; Šibensko-
kninska, 31; Virovitičko-podravska, 30; Vukovarsko-srijems-
ka, 96; Zadarska, 70; and Zagrebačka, 84.
Screening was performed in women who lacked breast 
physical examination abnormalities, including nipple dis-
charge, lumps, or thickening. Women with previous breast 
cancer and women who had not answered the questions 
addressing the studied risk factors were excluded.
Questionnaire. Women involved in the program were sent 
the questionnaire with an invitation letter to their home 
address. The invitation list was generated based on records 
of the Croatian Health Insurance Institute and the Ministry 
of Interior Affairs. The oldest women invited into the pro-
gram were born between 1937 and 1941. The participants 
at the time of mammography completed the question-
naire and reported their age, age at menarche, number 
of pregnancies and deliveries, age at first live-birth, histo-
ry and duration of breast feeding, use and duration of use 
of birth control pills (oral contraceptive), use and duration 
of hormone replacement therapy, menopausal status, age 
at menopause, personal or family history of breast cancer 
(defined as having first-degree or second-degree relative 
with breast cancer), breast symptoms (pain, tenderness, 
and swelling), breast procedures, weight, height, and the 
time of their last mammogram. To increase the response 
rate, reminders were made by telephone and field nurses 
motivated women to attend the screening.
BMI was calculated as self-reported current weight in ki-
lograms divided by height in meters squared (kg/m2) and 
divided into three categories: lean weight (BMI≤25), over-
weight (25<BMI<30), and obesity (BMI≥30) (17).
The patients gave informed consent when they filled 
in the questionnaire. The study was approved by the 
Ethics Committee of the Medical School, University 
of Zagreb.
Statistical analysis
Descriptive analysis and tabulations for all variables were per-
formed using χ2 test with Yates correction when necessary 
and two-sided t-tests to compare predictive variables for ur-
ban-rural differences (18,19). Statistical calculations were per-
formed using Statistica, version 9.0 (StatSoft, Tulsa, OK, USA).
reSultS
The first round of the population-based screening program 
included 204 352 women: 146 110 from 13 rural counties 
and 58 242 from the city of Zagreb (Figure 1, Table 1). We 
identified 924 women with breast cancer: 654 (0.45%) from 
rural areas and 270 (0.46%) from Zagreb. The detected can-
cer rate was 4.5 per 1000 mammographies in rural coun-
ties and 4.6 per 1000 mammographies in Zagreb (Table 1).
The  screening  program  involved  66  dedicated  screen-
ing facilities (47 in rural counties and 19 in Zagreb), with 
specialized equipment and trained staff who performed 
Figure 1.
Map of Croatia with 21 counties. 1 – Zagrebačka; 2 – Krapinsko-zagorska; 
3 – Sisačko-moslavačka; 4 – Karlovačka; 5 – Varaždinska (excluded due to 
lack of data); 6 – Koprivničko-križevačka;7 – Bjelovarsko-bilogorska; 8 – 
Primorsko-goranska*; 9 – ličko-senjska; 10 – Virovitičko-podravska; 11 – 
Požeško-slavonska; 12 – Brodsko-posavska; 13 – Zadarska; 14 – osiječko-
baranjska*;  15  –  Šibensko-kninska;  16  –  Vukovarsko-srijemska;  17 
– Splitsko-dalmatinska*; 18 – istarska*; 19 – dubrovačko-neretvanska*; 
20 – Međimurska*; 21 – City of Zagreb. asterisk indicates excluded coun-
ties with <50% rural inhabitant.79 Stamenić and Strnad: Urban-rural differences in breast cancer screening
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screening and/or for further assessment in cases when an 
abnormality was detected. There were only slight rural-ur-
ban differences in the number of screening facilities per 
10 000 invited women when all rural counties were consid-
ered, although there were great differences between indi-
vidual rural counties, from 0.8 in Brodsko-posavska county 
to 3.9 in Ličko-senjska county (Table 2).
The questionnaires were collected at the time of mammog-
raphy screening for 913 of the 924 women (99%) (Table 3). 
Compared with women from rural counties, significantly 
more women from Zagreb had the characteristics that in-
creased the risk of breast cancer: no pregnancies (15% vs 
7%), late age of first pregnancy (≥30-year) (10% vs 4%), and 
the last mammogram conducted 2-3 years ago (32% vs 
14%) (P < 0.001 for all comparisons). Compared with wom-
en from Zagreb, women from rural counties were more of-
ten obese – BMI>30 (41% vs 28%, respectively) and had 
early age of first live birth (<20 years) (20% vs 7%, P < 0.001 
for both comparisons, Table 3).
The participation rate was 59% in the city of Zagreb and 
61% in rural counties, ranging between 47% in Zagrebačka 
county and 78% in Bjelovarsko-bilogorska county (Table 
1). The number of screened women and reasons for non-
compliance with breast cancer screening recommenda-
tions varied between urban and rural counties (Table 4) 
and from county to county (Figure 2).
Women with breast cancer in Zagreb had lower parity 
than women in rural counties (91% vs 85%; P < 0.001). 
They also had significantly greater median age of first 
live birth (25 vs 19 years; P < 0.001) (Table 3).
taBle 1. the rate of screen-detected breast cancer per 1000 mammographies in 13 rural counties and the city of Zagreb in the first 
round of the “Mamma” screening program (2007-2009)
County of 
residence
Participating 
women, n (%)
Screened 
women
Screen-detected 
cancers
Cancer/per 1000 
mammographies
rural counties: 18 4 425 (60.6) 146 110 654 4.5
Vukovarsko-srijemska   18 446 (59.1)   15 122   96 6.3
Brodsko-posavska   14 112 (53.3)   12 406   64 5.1
Bjelovarsko-bilogorska   16 164 (78.1)   12 061   56 4.6
Zadarska   20 906 (69.9)   15 299   70 4.6
Zagrebačka   21 355 (47.0)   18 203   84 4.6
Koprivničko-križevačka   11 642 (63.8)   10 633   47 4.4
Požeško-slavonska   10 312 (74.6)   7 2 9 6   32 4.4
Ličko-senjska     4880 (47.9)   3 4 5 1   16 4.4
Virovitičko-podravska     9044 (61.1)   6 9 3 8   30 4.3
Karlovačka   12 436 (51.2)   9 6 6 2   42 4.3
Krapinsko-zagorska   13 438 (68.3)   11 598   41 3.5
Sisačko-moslavačka   18 998 (54.9)   13 712   45 3.3
Šibensko-kninska   12 692 (59.2)   9 7 2 9   31 3.2
urban county:
City of Zagreb   80 092 (58.5)   58 242 270 4.6
total 264 517 (59.6) 204 352 924 4.5
taBle 2. the number and rate of dedicated screening facilities 
per 10 000 invited women in 13 rural counties and the city of 
Zagreb in the “Mamma” screening program
County
of residence
invited
women
Screening
facilities
rate of screening 
facility per 10 000 
invited women
rural counties: 310 415 47 1.6
Ličko-senjska   10 176  4 3.9
Zagrebačka   45 421 11 2.4
Virovitičko-podravska   14 779  3 2.0
Krapinsko-zagorska   19 657  4 2.0
Šibensko-kninska   21 256  4 1.9
Požeško-slavonska   13 815  2 1.4
Sisačko-moslavačka   34 649  4 1.2
Koprivničko-križevačka   18 253  2 1.1
Zadarska   29 889  3 1.0
Bjelovarsko-bilogorska   20 675  2 1.0
Vukovarsko-srijemska   31 113  3 1.0
Karlovačka   24 289   3  1.0
Brodsko-posavska   26 443  2 0.8
urban county:
City of Zagreb 136 261 19 1.4
Total 446 676 66 1.5PUBLIC HEALTH 80 Croat Med J. 2011; 52: 76-86
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Most of the women with breast cancer in our study were 
postmenopausal (93% of rural and 94% of urban women; 
P = 0.455) (Table 3). There was no urban-rural difference in 
mean age at menarche (13.7 years in rural and 13.5 years 
Breast cancer 
patients, n (%)
Characteristic rural urban df χ2 P†
age at screening, years: 654 (100.0) 268 (99.3) 3 0.2487   0.969
50-54   91 (13.9)   40 (14.8)
55-59 150 (22.9)   61 (22.6)
60-64 143 (21.9)   60 (22.2)
65-69 270 (41.3) 107 (39.6)
mean age±SD   58.3 ± 11.4   61.2 ± 9.4
age at menarche, years:635 (97.1) 267 (98.9) 2   6.226   0.044
<12   38 (5.8)   26 (9.6)
12-13 251 (38.4) 115 (42.6)
≥14 346 (52.9) 126 (46.7)
mean age±SD   13.7 ± 3.6)   13.5 ± 3.5
Current menstrual 
status:
647 (98.9) 267 (98.9) 1   0.5584  0.455
pre-menopausal   37 (5.6)   12 (4.4)
peri/postmenopausal 610 (93.3) 255 (94.4)
age at menopause, 
years:
598 (91.4) 252 (93.3) 3   4.0369  0.257
<45   75 (12.3)   36 (14.1)
45-49 159 (26.1)   57 (22.3)
50-54 296 (48.5) 138 (54.1)
≥55   68 (11.1)   21 (8.2)
mean age±SD   49.0 ± 6.8   46.7 ± 6.9
use of oC (ever): 652 (99.7) 267 (98.9) 1   1.2244  0.268
no 538 (82.3) 212 (78.5)
yes 114 (17.4)   55 (20.4)
duration of oC use, 
years:
114 (17.4)   53 (20.4) 2   4.5337  0.104
<5   64 (55.4)   35 (63.6)
5-9   32 (28.6)     7 (12.7)
≥10   18 (16.1)   11 (20.0)
mean months±SD   52.6 ± 7.9   50.4 ± 7.4
use of hrt (ever): 652 (99.7) 267 (98.9) 1   9.5575  0.002
no 593 (90.9) 224 (83.0)
yes   59 (9.0)   43 (16.0)
duration of hrt use, 
years:
  59   43 2   1.0429  0.594
<5   19 (32.2)   18 (41.9)
5-9   25 (42.4)   15 (34.9)
≥10   15 (25.4)   10 (23.2)
mean months±SD   78.8 ± 8.3   74.7 ± 8.4
Pregnancy history: 644 (98.5) 267 (98.9) 1 14.2571<0.001
never pregnant   45 (6.9)   40 (14.8)
one pregnancy 113 (17.3)   43 (15.9)
≥2 pregnancies 486 (74.3) 184 (68.1)
median, range     2.0 (1-20)     2.0 (1-7)
Parity: 640 (97.8) 267 (98.9) 2 21.6220 <0.001
nulliparous   48 (7.3)   41 (15.2)
uniparous 134 (20.5)   74 (27.4)
multiparous 458 (70.0) 152 (56.3)
median (range)     2.0 (1-7)     2.0 (1-4)
age at first live birth, 
years:
592 (90.5) 255 (94.4) 3 45.4571<0.001
nulliparous   48 (7.3)   41 (15.2)
<20 132 (20.2)   20 (7.4)
20-29 388 (59.3) 166 (61.5)
≥30   24 (3.7)   28 (10.4)
mean age±SD   20.4 (4.6)   24.8 (4.9)
Period of breastfeeding, 
months:
632 (96.6) 259 (95.9) 2 11.5929   0.003
0 (include no live birth) 108 (16.5)   60 (22.2)
≤12 387 (59.2) 166 (61.5)
>12 137 (20.9)   33 (12.2)
mean months±SD   10.8 ± 3.2   8 . 8  ± 3.0
Family history of breast 
cancer:
652 (99.7) 255 (94.4) 2   8.1097   0.017
none 579 (88.5) 222 (82.2)
second degree   30 (4.6)   16 (5.9)
first degree   43 (6.6)   32 (11.8)
history of benign 
disease:
651 (99.5) 253 (93.7) 1   7.1417   0.007
no 568 (85.5) 203 (75.2)
yes   83 (12.7)   50 (18.5)
Body mass index: 632 (96.6) 270 (100) 2 21.3414 <0.001
<25 100 (15.0)   69 (25.5)
25.0-29.9 261 (40.2) 125 (46.3)
≥30 271 (41.4)   76 (28.1)
median weight (kg), 
range
  78.0 (40-
140)
  75.5 (48-
115)
height, cm 630 (96.3) 270 (100) 3   0.5630  0.905
<159 151 (23.3)   67 (28.1)
160-164 192 (29.6)   76 (28.1)
165-169 178 (27.1)   77 (28.5)
>170 109 (16.2)   50 (18.4)
mean±SD 163.4 (12.4) 163.9 (12.8)
*abbreviations: oC – oral contraceptive; Sd – standard deviation; hrt 
– hormonal replacement therapy; df – degrees of freedom.
†χ2 used to test categorical variables for statistical significance; t-tests 
were used on continuous variables.
Breast cancer 
patients, n (%)
Characteristic rural urban df χ2 P†
taBle 3. Characteristics of women with screen-detected breast cancer who participated in the first round of population-based 
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in urban women; P = 0.044) and at menopause (49 years in 
rural and 47 in urban women; P = 0.257). Fifteen percent 
of urban women and 7% of rural women had never been 
pregnant (P < 0.001; Table 3).
More women in rural counties had an average BMI>30 
(41% vs 28%; P < 0.001) and there was no difference in 
height between urban and rural women (163.4 vs 163.9 
cm, respectively) (P = 0.905) (Table 4).
Breast feeding was reported by 80% of rural women and 
74% of urban women (P = 0.039), and more rural wom-
en breast fed for longer than 12 months (21% vs 12%; 
P = 0.003) (Table 4).
There was no difference in the prevalence of postmeno-
pausal  breast  cancer  patients  between  rural  and  urban 
women (93% vs 94%, respectively; P = 0.455) (Table 3). The 
history of hormonal replacement therapy use was more 
common among urban than among rural women (16% vs 
9%, respectively; P = 0.003) but there was no difference in 
Figure 2.
differences between counties among invited women in the first round 
of breast cancer screening in Croatia, 2007-2009. Black – number of 
screened women; gray – women who did not attend screening; white – 
women who performed mammography in the past 12 months; diagonal 
lines – deceased women, women with wrong address, and women tem-
porarily out of Croatia.
taBle 4. the number of screened women and reasons for 
non-compliance with screening program after receiving an 
invitation, 2007-2009
no. (%) of women from
rural counties city of Zagreb
Screened women 146 110 (47.1)   58 242 (42.7)
reasons for non-compliance:
mammography <12mo   16 261 (5.2)   15 673 (11.5)
already receiving therapy     5482 (1.8)       303 (0.2)
other reason     7851 (2.5)     1014 (0.7)
deceased     4336 (1.4)       877 (0.6)
temporarily out of place of 
residence
    7673 (2.5)       550 (0.4)
not-attended 122 702 (39.5)   59 602 (43.7)
invited women 310 415 (100.0)136 261 (100.0)
taBle 5. the proportions of breast cancer risk factors among 924 patients with detected breast cancer who participated in the first 
round of the “Mamma” program
no. (%) of breast cancer patients
Characteristics rural (n = 654) urban (n = 270) difference (95% Ci) χ2  P
Body mass index >30 (kg/m2) 271 (41.4)   76 (28.1) 13.31 (6.52 to 19.66) 13.403 <0.001
Menarche:
<12   38 (5.9)   26 (9.7)   3.45 (0.45 to 7.34)   3.058   0.080
≥14 346 (52.9) 126 (46.5)   6.30 (-0.77 to 13.37)   2.778   0.095
Parity 590 (90.3) 231 (85.6)   4.76 (-0.01 to 9.53)   3.928   0.047
First live birth <20 y 132 (20.2)   20 (7.4) 12.78 (8.4 to 17.16) 21.794 <0.001
Breast-feeding 524 (80.1) 199 (73.7)   6.42 (0.34 to 12.5)   4.258   0.039
exogenous hormones:
oral contraceptive use (% ever) 114 (17.4)   55 (20.4)   2.94 (-2.67 to 8.5)   0.917   0.338
hormonal replacement therapy use (% ever)   59 (9.0)   43 (15.9)   6.90 (-2.01 to 11.78)   8.577   0.003
Breast cancer history:
in first-degree relative   43 (6.5)   32 (11.8)   5.28 (0.98 to 9.58)   6.456   0.011
in second-degree relative   30 (4.6)   15 (5.9)   1.34 (-1.9 to 4.58)   0.470   0.493
Prior screening before 2-3 y   94 (14.4)   85 (31.5) 17.11 (10.95 to 23.27) 34.735 <0.001
Breast symptoms 126 (19.2)   50 (18.6)   0.62 (4.92 to 6.16)   0.016   0.899
abbreviations: 95% Ci - 95% confidence interval.PUBLIC HEALTH 82 Croat Med J. 2011; 52: 76-86
www.cmj.hr
the history of oral contraceptive use (20% in urban wom-
en vs 17% in rural women; P = 0.338). Significantly more ru-
ral women had early age of the first live birth (<20 years) 
(20% vs 7%; P < 0.001). There was a significant urban-rural 
difference in having performed a mammogram in the last 
2 years (31% vs 14%, respectively; P < 0.001) (Table 5). More 
urban than rural women had a first-degree relative with 
breast cancer history (12% vs 7%; P = 0.011), and similar 
number of women from both groups had a second degree 
relative with breast cancer history (5% of rural vs 6% of ur-
ban women; P = 0.493) (Table 5).
diSCuSSion
Our study investigated urban-rural differences in the dis-
tribution of risk factors for breast cancer among women 
participating in the first round of the population-based 
screening program in Croatia. We found that women from 
Zagreb had significantly more characteristics associated 
with Western lifestyle that increased the risk of breast can-
cer (20), including no pregnancies, late age of first preg-
nancy (≥30 years), and mammographic examination in the 
last 2-3 years, while women from rural counties were more 
often obese and had younger age of first live birth (<20 
years).
Possible explanations for the less frequent use of preven-
tive services in rural counties than in Zagreb include great-
er distances to medical facilities, less access to services, 
and lower socioeconomic status (1). Indeed, we found that 
older age, living temporarily out of the place of residence, 
and greater distance from health services may be signifi-
cant barriers to the use of preventive health care services 
in rural areas. Economic concerns were not relevant to our 
study, since all women were invited to the free screening 
regardless of whether they were insured.
We found a similar level of screen-detected breast can-
cer rate per 1000 mammographies (4.6 vs 4.5) when all 
rural counties were considered, although our findings, 
as well as previous cancer incidence data in Croatia (13), 
showed great variation among rural counties, from 3.2 in 
Šibensko-kninska county to 6.3 in Vukovarsko-srijemska 
county.
After the first invitation round, the participation rate in 
Croatia stabilized at around 60%, which is lower than the 
70% rate that the EU Guidelines for Quality Assurance in 
Mammography Screening recommend as acceptable 
and the 75% rate that they recommend as desirable 
(21). The coverage varies considerably from program to 
program and from country to country (21-23). Attendance 
is naturally a strong predictor of the program’s impact, and 
the attendance rate of 61% in rural counties and 59% in 
Zagreb indicates that the program is well accepted, with 
no urban-rural gradient in screening participation, but ef-
forts have to be taken to achieve desirable participation 
rate  (14). The  participation  rate  showed  a  considerable 
variation between the counties, from 48% in Ličko-senjska 
county to 78% in Bjelovarsko-bilogorska county. This could 
be  explained  by  the  fact  that  Ličko-senjska  county  has 
more older residents and residents living temporarily out 
of their permanent place of residence and far from mam-
mography service facilities. Our results are similar to the 
study by McElroy, who found no significant difference in 
early detection of cancer between urban and rural com-
munities  (1).  On  the  other  hand,  the  Norwegian  Breast 
Cancer Screening program showed that rural areas had 
a greater attendance rate than Oslo (90% vs 79%), which 
most probably reflected different access to private mam-
mography services (23). Screening attendance might be 
affected by false-positive mammography and overdiagno-
sis in organized mammography screening (24,25).
There are no uniformly accepted definitions of rural and ur-
ban areas and this makes the comparison between studies 
difficult (26). Also, within a single county there are hetero-
geneous populations and environments, which is likely to 
mask trends at smaller geographical levels. However, a few 
studies have evaluated patterns of urban/rural risk even at 
such levels (27,28). Future studies should examine rural/
urban differences in conjunction with other risk factors at 
different geographical levels, such as neighborhood block, 
tract, or city (29).
Contrary to our findings, Chelpin et al (23) found a higher 
coverage in the mixed urban-rural area in Fyn (20%) than 
in Copenhagen; Thurfjell et al (30) found a lower participa-
tion rate in Stockholm than in rural Sweden; and Vizcaino 
et al (31) found a lower participation rate in Valencia than 
in Navarra.
On the other hand, Blair et al found substantial differ-
ences in the distribution of breast cancer and probable 
risk factors (parity, age at first full-term pregnancy, breast-
feeding, age at menarche, age at menopause, and alcohol 
consumption) between the urban San Francisco Bay Area 
and rural regions (6). Increased breast cancer incidence 
rate in the San Francisco Bay Area could be completely ac-
counted for by regional differences in known risk factors 83 Stamenić and Strnad: Urban-rural differences in breast cancer screening
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(2). Studies on migration, acculturation, and breast can-
cer incidence demonstrate that incidence rates increase 
in women who migrate from low-incidence to high-inci-
dence countries (32).
Our study found a significantly higher proportion of obe-
sity among postmenopausal rural women (BMI≥30), which 
is in accordance with previous results (33-39). This differ-
ence may be explained by a high-fat diet and lower socio-
economic status in rural women (40).
A family history of breast cancer has long been recognized 
as a risk factor for the disease, and the risk of developing 
breast cancer is increased 1.5- to 3-fold if a woman has 
mother or sister with breast cancer (41). Our study found 
a higher proportion of first degree relatives with breast 
cancer among urban women. These women are at high-
er risk of breast cancer than general population because 
of shared genetic factors and possibly because of shared 
exposures to environmental and lifestyle factors (42). The 
recent identification of common genetic variants, howev-
er, has not heralded the arrival of personalized prevention 
measures of breast cancer, although it has been recom-
mended that these women undergo annual mammogra-
phy screening beginning with the age of 40 years (43).
Our findings suggest that mammographic screening has 
played a major role in the increase in incidence of breast 
cancer in Croatia (13), but the increase had started well 
before the screening became widely available (44). The in-
creasing trends observed before 1995 can be attributed 
to greater disease awareness, greater detection by physi-
cal breast examination (either self-examination or exami-
nation by physician or a nurse), changes in reproductive 
factors, increasing use of hormone treatment after meno-
pause, and increasing rates of obesity (39).
Epidemiological  studies  have  consistently  identified  a 
number of breast cancer risk factors associated with in-
creased exposure to endogenous estrogens (41,43-47). 
Our findings suggest that the observed differences be-
tween urban and rural women could be substantially re-
duced by changing the lifestyle, reducing obesity, and 
promoting breast feeding. It is important to educate the 
public and health care professionals in order to promote 
mammography screening (48,49), including the “Mam-
ma” program. Finally, obesity, which increases the risk of 
many adverse health conditions including breast cancer, 
needs to be addressed through effective community in-
terventions.
This study has several strengths: population-based design, 
the response rate of 99%, and availability of information 
on many established and probable risk factors that may in-
fluence breast cancer, with no recall bias. However, one of 
its limitations is that the questionnaire did not distinguish 
among types of hormone replacement therapy. Also the 
data on socioeconomic status, such as education, income, 
type of occupation, and in some populations, ethnicity, 
and religion were missing (32). Besides this, the data were 
self-reported and therefore not verified by objective ob-
servers. Future studies should take into account both the 
women’s attitude toward screening and the consistency of 
women’s behavioral pattern (23,50-52). In addition, most 
research examines rural-urban residence at the time of the 
diagnosis, but does not examine exposures at critical life 
stages. Future research should examine residential histo-
ry to analyze the critical exposures or timing of exposures 
that lead to greater breast cancer incidence.
In conclusion, our study identified several reproductive 
and anthropometric risk factors for breast cancer that are 
modifiable and can reduce inequalities between urban 
and rural areas. Although there are some effective pro-
grams that may reduce some of the preventable risk fac-
tors, the availability of these programs may need to be im-
proved in several remote rural areas. Future studies should 
implement the Gail breast cancer risk prediction model 
(53,54) to explore how the distribution of established risk 
factors could explain the high incidence of breast can-
cer  in  some  counties  (Dubrovačko-neretvanska,  Zadar-
ska, Primorsko-goranska, and Istarska county) but not in 
other (Krapinsko-zagorska, Šibensko-kninska, Virovitičko-
podravska,  and  Zagrebačka  county). The  current  coun-
ty differences in breast cancer incidence may reflect dif-
ferences in risk factor prevalence but also differences in 
screening mammography use.
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